12:34 PM EST, 03/05/2025 (MT Newswires) -- BioNexus Gene Lab ( BGLC ) said Wednesday its board has approved its Ethereum-focused treasury strategy, prioritizing Ethereum as a strategic treasury asset.
The company said Ethereum presents a strategic treasury management solution due partly to its institutional credibility and yield-generation capabilities.